1-4 of 4
Jason B. Fleming
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma

Kristina Y. Aguilera, Huocong Huang, Wenting Du, Moriah M. Hagopian, Zhen Wang, Stefan Hinz, Tae Hyun Hwang, Huamin Wang, Jason B. Fleming, Diego H. Castrillon, Xiaomei Ren, Ke Ding, Rolf A. Brekken
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (11): 2473–2485.
https://doi.org/10.1158/1535-7163.MCT-16-0834
Published: 01 November 2017
View article titled, Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma
Open the PDF for Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma

Bingbing Dai, David Roife, Ya'an Kang, Joy Gumin, Mayrim V. Rios Perez, Xinqun Li, Michael Pratt, Rolf A. Brekken, Juan Fueyo-Margareto, Frederick F. Lang, Jason B. Fleming
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (4): 662–670.
https://doi.org/10.1158/1535-7163.MCT-16-0526
Published: 02 April 2017
View article titled, Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
Open the PDF for Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract B13: Salmonella typhimurium A1-R targets human pancreatic cancer patient-derived orthotopic xenograft (PDOX) in nude mice.

Yukihiko Hiroshima, Ming Zhao, Ali Maawy, Yong Zhang, Matthew H.G. Katz, Jason B. Fleming, Fuminari Uehara, Shinji Miwa, Shuya Yano, Masashi Momiyama, Atsushi Suetsugu, Takashi Chishima, Kuniya Tanaka, Michael Bouvet, Itaru Endo, Robert M. Hoffman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B13.
https://doi.org/10.1158/1535-7163.TARG-13-B13
Published: 01 November 2013
View article titled, Abstract B13: Salmonella typhimurium A1-R targets human pancreatic cancer patient-derived orthotopic xenograft (PDOX) in nude mice.
Journal Articles

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Davide Melisi, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, Paul J. Chiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 829–840.
https://doi.org/10.1158/1535-7163.MCT-07-0337
Published: 15 April 2008
View article titled, LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Open the PDF for LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis in another window
Includes: Supplementary data